Search
for

    Sort by

    Research 211–240 of 1000+

    1. COMPARITIVE STUDY OF TOPICAL MINOXIDIL (5%) PLUS FINASTERIDE (0.1%) VERSUS PLATELET-RICH PLASMA PLUS TOPICAL MINOXIDIL (5%) PLUS FINASTERIDE (0.1%) IN PATIENTS WITH ANDROGENIC ALOPECIA Asian Journal of Pharmaceutical and Clinical Research · 2024
    2. ROBOTIC HAIR TRANSPLANTATION – ARTIFICIAL INTELLIGENCE PLUS HUMAN TOUCH Wiadomości Lekarskie · 2024
    3. Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome Metabolites · 2023
    4. Evaluation of platelet‐rich plasma plus basic fibroblast growth factor combined with minoxidil in the treatment of androgenetic alopecia: A randomized controlled trial Journal of Cosmetic Dermatology · 2023
    5. A comparison between flutamide and finasteride plus flutamide combination in the treatment of hirsutism 10th European Congress of Endocrinology · 2008
    6. “Efficacy of Platelet-Rich Plasma Plus Basic Fibroblast Growth Factor on the Treatment of Androgenic Alopecia” Plastic and Reconstructive Surgery · 2022
    7. A COMPARATIVE STUDY OF COMBINED MICRONEEDLING PLUS PLATELET-RICH PLASMA THERAPY VERSUS MICRONEEDLING ALONE IN 50 PATIENTS OF ANDROGENIC ALOPECIA PARIPEX INDIAN JOURNAL OF RESEARCH · 2021
    8. Effectiveness of Topical Minoxidil (5%) Plus Topical Finasteride (0.1%) Fixed-Dose Combination Versus Topical Minoxidil (5%) Plus Oral Finasteride (1 Mg/Day) in Grade II-IV Androgenetic Alopecia: A Randomized, Double Blind Clinical Trial Asian Journal of Research in Dermatological Science · 2021
    9. Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss Case medical research · 2019
    10. A comparative study of microneedling with PRP plus minoxidil (5%) and minoxidil (5%) alone in androgenetic alopecia Journal of The American Academy of Dermatology · 2017
    11. A comparative study of microneedling with platelet-rich plasma plus topical minoxidil (5%) and topical minoxidil (5%) alone in androgenetic alopecia International Journal of Trichology · 2017 · 48 citations
    12. Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome International Journal of Gynecology & Obstetrics · 2008 · 35 citations
    13. The Phenotypic and Genotypic Spectra of Ichthyosis With Confetti Plus Novel Genetic Variation in the 3′ End of<i>KRT10</i> JAMA dermatology · 2014 · 22 citations
    14. Evaluation of the efficacy of transdermal drug delivery of calcipotriol plus betamethasone versus tacrolimus in the treatment of vitiligo Journal of Cosmetic Dermatology · 2018 · 18 citations
    15. Biotin and Acetazolamide for Treatment of an Unusual Child With Autism Plus Lack of Nail and Hair Growth Pediatric neurology · 2017 · 10 citations
    16. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study Journal of Clinical Medicine · 2022 · 6 citations
    17. DICENTRIC CHROMOSOME 14;18 PLUS TWO ADDITIONAL CNVs IN A GIRL WITH MICROFORM HOLOPROSENCEPHALY AND TURNER STIGMATA Balkan Journal of Medical Genetics · 2013 · 3 citations
    18. A comparative study of efficacy of 5% minoxidil and 5% minoxidil plus platelet-rich plasma in same patient for treatment of androgenetic alopecia Journal of Cutaneous and Aesthetic Surgery · 2022 · 1 citations
    19. 0519 Social media claims and tolerability of topical tretinoin plus topical minoxidil for androgenetic alopecia Journal of Investigative Dermatology · 2026
    20. COMPARISON OF THERAPEUTIC EFFICACY OF MICRONEEDLING WITH PLATELET-RICH PLASMA PLUS 5% MINOXIDIL AND 5% MINOXIDIL ALONE IN ANDROGENETIC ALOPECIA Journal of Population Therapeutics and Clinical Pharmacology · 2025
    21. Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes. Journal of Clinical Oncology · 2018
    22. Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model The Journal of Urology · 2022
    23. The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women With Menstrual Irregularity Plus Hyperandrogenism Reproductive Sciences · 2011 · 32 citations
    24. A Randomized Double-Blind Placebo-Controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition, and Metabolic Profile in Transmen The Journal of Sexual Medicine · 2021 · 7 citations
    25. The anti-androgen combination, flutamide plus finasteride, paradoxically suppressed LH and androgen concentrations in pregnant spotted hyenas, but not in males General and Comparative Endocrinology · 2010 · 5 citations
    26. Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial Frontiers in Medicine · 2022 · 2 citations
    27. Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C PLOS ONE · 2019 · 2 citations
    28. A Randomised Controlled Single Observer Blinded Study To Determine The Efficacy Of Topical Minoxidil Plus Microneedling Versus Topical Minoxidil In The Treatment Of Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2025
    29. A Randomised Controlled Single Observer Blinded Study To Determine The Efficacy Of Topical Minoxidil Plus Microneedling Versus Topical Minoxidil In The Treatment Of Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2025
    30. BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer ESMO Gastrointestinal Oncology · 2024